In the published article, there was an error in the order of the affiliations. The original list read:
Nándor Polk1, Barna Budai2,*, Erika Hitre3, Attila Patócs2,4,5 and Tamás Mersich1
1Departmet of Visceral Surgery, National Institute of Oncology, Budapest, Hungary
2Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary
3Medical Oncology and Clinical Pharmacology “B” Department, National Institute of Oncology, Budapest, Hungary
4Clinical Central Laboratory, National Institute of Oncology, Budapest, Hungary
5Department of Laboratory Medicine, Semmelweis University, Budapest, Hungary
The corrected list is:
Nándor Polk2, Barna Budai3,*, Erika Hitre4, Attila Patócs1,3,5,* and Tamás Mersich2
1Department of Laboratory Medicine, Semmelweis University, Budapest, Hungary
2Departmet of Visceral Surgery, National Institute of Oncology, Budapest, Hungary
3Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary
4Medical Oncology and Clinical Pharmacology “B” Department, National Institute of Oncology, Budapest, Hungary
5Clinical Central Laboratory, National Institute of Oncology, Budapest, Hungary
A new corresponding author has been included. The correct correspondence footnote is:
*Correspondence: Barna Budai, budai.barna@oncol.hu; Attila Patócs, patocs.attila@med.semmelweis-univ.hu
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Summary
Keywords
neutrophil-to-lymphocyte ratio, liver-only metastases of rectal cancer, metastasectomy, relapse-free survival, systemic immune-inflammation index, liver-only metastases of colon cancer, preoperative treatment
Citation
Polk N, Budai B, Hitre E, Patócs A and Mersich T (2022) Corrigendum: High Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammation Index (SII) are Markers of Longer Survival After Metastasectomy of Patients With Liver-Only Metastasis of Rectal Cancer. Pathol. Oncol. Res. 28:1610658. doi: 10.3389/pore.2022.1610658
Received
17 June 2022
Accepted
20 July 2022
Published
06 October 2022
Volume
28 - 2022
Edited by
Andrea Ladányi, National Institute of Oncology (NIO), Hungary
Updates
Copyright
© 2022 Polk, Budai, Hitre, Patócs and Mersich.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Barna Budai, budai.barna@oncol.hu; Attila Patócs, patocs.attila@med.semmelweis-univ.hu
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.